efe-epaNew York

American pharmaceutical company Moderna said Monday that its Covid-19 vaccine neutralizes the British and South African variants of the virus that causes that potentially fatal respiratory illness.

Results from in vitro neutralization studies showed broad effectiveness of the two-dose Moderna vaccine, which has been approved for emergency use in the United States, the European Union, the United Kingdom and elsewhere. EFE-EPA